Home › Autoimmune Diseases › Ohio
Autoimmune Diseases clinical trials in Ohio
13 studies for Autoimmune Diseases are looking for participants at sites in Ohio.
Cities in Ohio
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1038, Cincinnati
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Nov 13, 2026 · NCT07039916Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Nov 12, 2026 · NCT06056297A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06948318Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases
- The Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT06626919Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Cleveland Clinic Foundation, Cleveland
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 21, 2026 · NCT07513181Abatacept for the Treatment of Giant Cell Arteritis
- Cleveland Clinic, Cleveland
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Aug 20, 2026 · NCT04474847Study of BHV-1300 in Graves' Disease
- Site-110, Canton
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Case Medical Center, Cleveland
- and 3 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
Recruiting
Ages 18 to 65 · All sexes · Updated Feb 20, 2026 · NCT07424027IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 29, 2023 · NCT05883371From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.